comparemela.com

Page 9 - Jim Polson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pharming Group N V : Pharming Announces Positive Data from Phase II/III Leniolisib Trial Presented at Clinical Immunology Society 2022 Annual Meeting

LEIDEN, Netherlands, April 1, 2022 /PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces new data from the pivotal Phase II/III

Pharming announces positive results of Phase II/III pivotal clinical study of leniolisib for the treatment of activated PI3K delta syndrome

vimarsana © 2020. All Rights Reserved.